“…Moreover, hemolysis occurred after device closure of patent ductus arteriosus in 2 of the other patients with no residual shunt. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Eleven scientific databases (PubMed, Web of Science, SciELO, Koreamed, Jstage, AMED, CENTRAL, PEDro, IEEE, Scopus, and Arxiv) and five patent databases (Patentscope, Patentlens, Google Patents, Kripis, J-platpat) were searched. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND/OBJECTIVE: Although most research universities offer investigators help in obtaining patents for inventions, investigators generally have few resources for scaling up non-patentable innovations, such as health behavior change interventions. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In addition, the disaggregated asymmetric effects of technological innovation (patent resident and patent nonresident) on CO(2) are also captured in this study. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…These savings range from €984 million to €993 million as the delay between patent and generic marketing authorisation varies from 10 to 15 years, and from €965 million to €993 million as the Negotiated Price per Unit (NPU) of generics at market-entry varies from 40 to 50% of the NPU for patents. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Patel, ASM: Board Member, None CD Diagnostics, BioFire, Curetis, Merck, Hutchison Biofilm Medical Solutions, Accelerate Diagnostics, Allergan, and The Medicines Company: Grant Investigator, Grant recipient Curetis: Consultant, Monies paid to my employer A patent on Bordetella pertussis/parapertussis PCR issued, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic, and a patent on an anti-biofilm substance issued: Patents, Patents, any money is paid to my employer Actelion: DSMB, Money paid to my employer ASM and IDSA: Editor’s stipends, Editor’s stipends NBME, Up-to-Date and the Infectious Diseases Board Review Course: NBME, Up-to-Date and the Infectious Diseases Board Review Course, Honoraria…”
Enlace del recurso
Enlace del recurso

“…Patel, ASM: Board Member, None; CD Diagnostics, BioFire, Curetis, Merck, Hutchison Biofilm Medical Solutions, Accelerate Diagnostics, Allergan, and The Medicines Company: Grant Investigator, Grant recipient; Curetis: Consultant, Monies paid to my employer; A patent on Bordetella pertussis/parapertussis PCR issued, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic, and a patent on an anti-biofilm substance issued: Patents, Patents, any money is paid to my employer; Actelion: DSMB, Money paid to my employer; ASM and IDSA: Editor’s stipends, Editor’s stipends; NBME, Up-to-Date and the Infectious Diseases Board Review Course: NBME, Up-to-Date and the Infectious Diseases Board Review Course, Honoraria; Roche, ASM, and IDSA: Travel reimbursement, Travel reimbursement…”
Enlace del recurso
Enlace del recurso

“…The idea of colliding two particle beams to fully exploit the energy of accelerated particles was first proposed by Rolf Wideröe, who in 1943 applied for a patent on the collider concept and was awarded the patent in 1953. …”
Enlace del recurso

“…The second recommendation builds upon the first recommendation: if two sets of intellectual property protection legislation are enacted, patents on essential medications should be restricted to patents on processes rather than the product itself. …”
Enlace del recurso
Enlace del recurso

“…We present a rare case of main pulmonary artery stenosis secondary to protruding fibrous material in the main pulmonary artery associated with patent ductus arteriosus. A 1-month-old baby boy manifested cardiac murmur. …”
Enlace del recurso
Enlace del recurso

“…We developed a computational screen that tests an individual's genome for mutations in the BRCA genes, despite the fact that both are currently protected by patents.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…ABSTRACT: BACKGROUND: Recent patent losses for antiretroviral drugs (ARV) have led to the debate of cost-saving through the replacement of patented drugs with generic drugs. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A morphologically distinct isolate of Cladosporium sphaerospermum from a North American patent collection, referenced as Cladosporium lignicola in the patent, was examined. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…There are several types of intellectual property protection like patent, copyright, trademark, etc. Patent is a recognition for an invention, which satisfies the criteria of global novelty, non-obviousness, and industrial application. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Preoperative coronary angiography showed patent distal graft anastomoses and visualized the left ITA retrogradely. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Congenital rubella infection is a transplacental infection that can cause intrauterine growth retardation, cataracts, patent ductus arteriosus, hearing loss, microcephaly, thrombocytopenia, and severe fetal injury. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The REpurposing Drugs in Oncology (ReDO) project investigates the potential use of off patent non-cancer drugs as sources of new cancer therapies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…She was found to have a small patent foramen ovale (PFO), but due to the late appearances of bubbles on the bubble study it was thought that this was an incidental finding. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Brand name drugs are costlier as compared to generic and branded generic drugs because they are innovator molecules developed by a company after many years of research and come into the market with a patent, whereas branded generic drugs are produced by a different company once the patent of innovator company expires. …”
Enlace del recurso
Enlace del recurso

“…Overall, molnupiravir has been obtained in a 41% overall isolated yield compared to a maximum 17% isolated yield in the patented route. This route provides many advantages to the initial route described in the patent literature and would decrease the cost of this pharmaceutical should it prove safe and efficacious in ongoing clinical trials.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso